Novartis Investigative Site

Esplugues de Llobregat, Barcelona 08950

0 studies enrolling now · 10 studies all time

What they study most

Allergy, Peanut, B-cell Acute Lymphoblastic Leukemia, Chronic Severe Plaque-type Psoriasis, Chronic Spontaneous Urticaria, Heart Failure, Hereditary Periodic Fevers, Moderate to Severe Chronic Plaque-type Psoriasis, Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant, Systemic Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis (SJIA)

Studies at this site

• Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis — Completed
• Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF — Completed
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy — Stopped early
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early
• Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients — Completed
• Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis — Completed
• ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab — Completed
• Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients — Completed
• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. — Completed
• Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers — Completed